Market Dynamics
NGS is used in a variety of applications, including biomarker exploration, oncology trials, personalized medicine, agricultural and animal testing, and so on. NGS has simplified nucleotide analysis and has effectively replaced traditional genomics tools, especially microarrays. As a result, the aforementioned factors contribute to the growth of the global next-generation sequencing market share. The market is expected to expand due to factors such as technological advances, increased NGS applications, and an increase in genome mapping programs. Furthermore, market growth is expected to be fueled by the demand for personalized medicine and rapid advancements in companion diagnostics production. Because of technical advances in NGS, an increase in NGS applications, and an increase in alliances and collaborations, the global next generation sequencing market is growing. Furthermore, the increase in genome mapping programs propels the global next generation sequencing market forward.
Market Segmentation
The Global Next-Generation Sequencing Market has been segmented into Technology, Workflow, Application, End User, and Region.
Based on technology, the global next-generation sequencing market has been divided into targeted sequencing & resequencing, whole-genome sequencing, and whole-exome sequencing.
Based on workflow, the global next-generation sequencing market has been divided into pre-sequencing, sequencing, and data analysis.
The global next-generation sequencing market, by applications, has been segmented into oncology, clinical investigation, reproductive health, human leukocyte antigen typing or immune system monitoring, metagenomics, epidemiology, and drug development, agrigenomics & forensics, consumer genomics, and others.
The global next-generation sequencing market, by end-user, has been segmented into hospitals & clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others.
Competitive Landscape
Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), Genome Life Sciences (India), GenScript (US), Illumina, Inc. (US), Thermo Fisher Scientific (US), Qiagen (Germany), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California, Inc. (US), Xcelris Genomics (India), Macrogen, Inc. (South Korea), BGI (US), Charles River (US), and Oxford Nanopore Technologies (UK) are some of the key players operating in the global next generation sequencing market.
Key Market Opportunities
Favorable funding scenario and immense support for scientific research would augment the next-generation sequencing
READ MORE @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354
Key Market Drivers
Rising technological advancements, increasing applications of NGS, and growth in genome mapping programs.
Increasing demand for personalized medicine and high growth in the development of companion diagnostics
RELATED REPORTS
Dental Carpule Market Research Report - Global Forecast to 2027
Global Medically prescribed apps Market Report - Forecast to 2027
Global Leuprolide Acetate Market Research Report - Forecast to 2027
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
